vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and Snail, Inc. (SNAL). Click either name above to swap in a different company.

Snail, Inc. is the larger business by last-quarter revenue ($25.1M vs $19.2M, roughly 1.3× Apyx Medical Corp). Snail, Inc. runs the higher net margin — -3.4% vs -6.8%, a 3.3% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -4.2%). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 33.4%).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

Suzhou Snail Digital Technology Co., Ltd., doing business as Snail, is a Chinese video game company and a Virtual Network Operator headquartered in Suzhou, China, which has branches Snail Games and Snail Mobile. Its division, Snail USA, markets Snail Games products in North America, South America, & Europe. Snail Games products include massively multiplayer online (MMOs), real-time strategy (RTS), and casual games. Its global registered user base has reached over 70 million accounts. The U.S....

APYX vs SNAL — Head-to-Head

Bigger by revenue
SNAL
SNAL
1.3× larger
SNAL
$25.1M
$19.2M
APYX
Growing faster (revenue YoY)
APYX
APYX
+39.0% gap
APYX
34.7%
-4.2%
SNAL
Higher net margin
SNAL
SNAL
3.3% more per $
SNAL
-3.4%
-6.8%
APYX
Faster 2-yr revenue CAGR
APYX
APYX
Annualised
APYX
36.8%
33.4%
SNAL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
APYX
APYX
SNAL
SNAL
Revenue
$19.2M
$25.1M
Net Profit
$-1.3M
$-862.2K
Gross Margin
62.6%
38.3%
Operating Margin
0.1%
-6.0%
Net Margin
-6.8%
-3.4%
Revenue YoY
34.7%
-4.2%
Net Profit YoY
71.9%
-177.0%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
SNAL
SNAL
Q4 25
$19.2M
$25.1M
Q3 25
$12.9M
$13.8M
Q2 25
$11.4M
$22.2M
Q1 25
$9.4M
$20.1M
Q4 24
$14.2M
$26.2M
Q3 24
$11.5M
$22.5M
Q2 24
$12.1M
$21.6M
Q1 24
$10.2M
$14.1M
Net Profit
APYX
APYX
SNAL
SNAL
Q4 25
$-1.3M
$-862.2K
Q3 25
$-2.0M
$-7.9M
Q2 25
$-3.8M
$-16.6M
Q1 25
$-4.2M
$-1.9M
Q4 24
$-4.6M
$1.1M
Q3 24
$-4.7M
$235.1K
Q2 24
$-6.6M
$2.3M
Q1 24
$-7.6M
$-1.8M
Gross Margin
APYX
APYX
SNAL
SNAL
Q4 25
62.6%
38.3%
Q3 25
64.4%
0.1%
Q2 25
62.3%
31.3%
Q1 25
60.1%
29.1%
Q4 24
63.0%
43.3%
Q3 24
60.5%
38.6%
Q2 24
61.7%
37.5%
Q1 24
58.1%
14.7%
Operating Margin
APYX
APYX
SNAL
SNAL
Q4 25
0.1%
-6.0%
Q3 25
-6.5%
-71.3%
Q2 25
-22.6%
-8.2%
Q1 25
-32.4%
-20.4%
Q4 24
-21.4%
11.5%
Q3 24
-31.6%
1.8%
Q2 24
-45.7%
12.4%
Q1 24
-64.6%
-15.6%
Net Margin
APYX
APYX
SNAL
SNAL
Q4 25
-6.8%
-3.4%
Q3 25
-15.4%
-56.9%
Q2 25
-33.2%
-74.7%
Q1 25
-44.0%
-9.7%
Q4 24
-32.5%
4.3%
Q3 24
-40.9%
1.0%
Q2 24
-54.0%
10.4%
Q1 24
-74.0%
-12.6%
EPS (diluted)
APYX
APYX
SNAL
SNAL
Q4 25
Q3 25
Q2 25
$-0.44
Q1 25
$-0.06
Q4 24
$0.03
Q3 24
$0.01
Q2 24
$-0.19
$0.06
Q1 24
$-0.22
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
SNAL
SNAL
Cash + ST InvestmentsLiquidity on hand
$31.7M
$8.6M
Total DebtLower is stronger
$37.5M
$14.6M
Stockholders' EquityBook value
$14.5M
$-16.4M
Total Assets
$66.8M
$59.3M
Debt / EquityLower = less leverage
2.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
SNAL
SNAL
Q4 25
$31.7M
$8.6M
Q3 25
$25.1M
$12.3M
Q2 25
$29.3M
$7.9M
Q1 25
$31.0M
$9.4M
Q4 24
$31.7M
$7.3M
Q3 24
$28.0M
$10.6M
Q2 24
$32.7M
$15.5M
Q1 24
$37.3M
$16.1M
Total Debt
APYX
APYX
SNAL
SNAL
Q4 25
$37.5M
$14.6M
Q3 25
$37.5M
$10.5M
Q2 25
$37.5M
$11.8M
Q1 25
$37.5M
$9.0M
Q4 24
$37.5M
$5.7M
Q3 24
$37.5M
$5.7M
Q2 24
$5.8M
Q1 24
$6.5M
Stockholders' Equity
APYX
APYX
SNAL
SNAL
Q4 25
$14.5M
$-16.4M
Q3 25
$5.8M
$-15.6M
Q2 25
$7.3M
$-8.0M
Q1 25
$10.5M
$9.1M
Q4 24
$14.2M
$9.7M
Q3 24
$11.0M
$8.2M
Q2 24
$14.7M
$7.9M
Q1 24
$20.3M
$5.6M
Total Assets
APYX
APYX
SNAL
SNAL
Q4 25
$66.8M
$59.3M
Q3 25
$57.4M
$51.1M
Q2 25
$58.2M
$58.0M
Q1 25
$60.2M
$64.5M
Q4 24
$64.8M
$62.2M
Q3 24
$60.7M
$66.8M
Q2 24
$65.4M
$75.4M
Q1 24
$70.7M
$78.3M
Debt / Equity
APYX
APYX
SNAL
SNAL
Q4 25
2.58×
Q3 25
6.41×
Q2 25
5.17×
Q1 25
3.57×
0.99×
Q4 24
2.64×
0.59×
Q3 24
3.40×
0.70×
Q2 24
0.73×
Q1 24
1.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
SNAL
SNAL
Operating Cash FlowLast quarter
$-2.5M
$-5.3M
Free Cash FlowOCF − Capex
$-2.8M
FCF MarginFCF / Revenue
-14.6%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
SNAL
SNAL
Q4 25
$-2.5M
$-5.3M
Q3 25
$-3.5M
$6.6M
Q2 25
$-1.2M
$-3.2M
Q1 25
$-702.0K
$764.5K
Q4 24
$-2.9M
$-3.6M
Q3 24
$-4.4M
$-5.0M
Q2 24
$-4.3M
$206.6K
Q1 24
$-6.3M
$6.8M
Free Cash Flow
APYX
APYX
SNAL
SNAL
Q4 25
$-2.8M
Q3 25
$-4.1M
Q2 25
$-1.5M
Q1 25
$-757.0K
Q4 24
$-3.2M
Q3 24
$-4.6M
Q2 24
$-4.6M
Q1 24
$-6.4M
FCF Margin
APYX
APYX
SNAL
SNAL
Q4 25
-14.6%
Q3 25
-31.5%
Q2 25
-13.2%
Q1 25
-8.0%
Q4 24
-22.4%
Q3 24
-40.0%
Q2 24
-38.0%
Q1 24
-62.2%
Capex Intensity
APYX
APYX
SNAL
SNAL
Q4 25
1.4%
Q3 25
4.0%
Q2 25
2.3%
Q1 25
0.6%
Q4 24
1.7%
Q3 24
1.3%
Q2 24
2.4%
Q1 24
0.3%
Cash Conversion
APYX
APYX
SNAL
SNAL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-3.21×
Q3 24
-21.05×
Q2 24
0.09×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APYX
APYX

Segment breakdown not available.

SNAL
SNAL

Pc$14.7M59%
Platform Three$5.2M21%
Platform Two$3.3M13%
Sales Channel Directly To Consumer Mobile Sale$1.6M6%

Related Comparisons